Newbridge Financial Services Group, Inc. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 295 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Newbridge Financial Services Group, Inc. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$5,167
-0.9%
334
+0.6%
0.00%0.0%
Q2 2023$5,212
-4.7%
3320.0%0.00%0.0%
Q1 2023$5,467
+5.6%
3320.0%0.00%0.0%
Q4 2022$5,175
+29.4%
332
+0.9%
0.00%
+50.0%
Q3 2022$4,000
-20.0%
329
+0.6%
0.00%
-33.3%
Q2 2022$5,0000.0%3270.0%0.00%
+50.0%
Q1 2022$5,000
+25.0%
3270.0%0.00%0.0%
Q4 2021$4,000
+100.0%
327
+149.6%
0.00%
+100.0%
Q3 2021$2,0000.0%131
+2.3%
0.00%0.0%
Q2 2021$2,0000.0%1280.0%0.00%0.0%
Q1 2021$2,0001280.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2021
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders